November 9, 2026 · Lancet (London, England) · DOI: 10.1016/S0140-6736(26)02140-9

Cardiovascular outcomes with survodutide in adults with obesity at increased cardiovascular risk (SYNCHRONIZE-CVOT): a double-blind, randomised, placebo-controlled, phase 3 trial.

Listen to this summary

SYNCHRONIZE-CVOT asked whether the dual glucagon/GLP-1 receptor agonist survodutide is cardiovascularly safe in adults with obesity and either established cardiovascular disease, chronic kidney disease, or elevated cardiovascular risk. In this randomised, placebo-controlled trial of 5,530 participants followed for a median of 22 months, the primary composite endpoint occurred in 3.7% of survodutide-treated participants versus 4.1% on placebo (HR 0.89, 95% CI 0.67–1.18), meeting the prespecified non-inferiority criterion. Gastrointestinal adverse events, particularly nausea and vomiting, were substantially more common with survodutide, though serious adverse event rates were similar across groups.

Biykem Bozkurt, Carel W le Roux, Sean Wharton, Jawad H Butt, Elena Startseva, Mikhail Sumin, S Renée Marshall, Samina Ajaz Hussain, Sven Schnaidt, Mark C Petrie, Stuart J Pocock, John Gregson, Jamy D Ard, Pawel Bogdanski, Cintia Cercato, Javier M Farias, Assen Goudev, Jøran Hjelmesæth, Upendra Kaul, Alexander D Kokkinos, Wen-Yuan Lin, Martin Matoulek, Béla Merkely, José Silva-Nunes, Wataru Ogawa, Sue D Pedersen, Kirsi H Pietiläinen, Naveed Sattar, Leobardo Sauque Reyna, Morten Schou, Jochen Seufert, Almaz Sharman, Harald Sourij, Francisco J Tinahones, André P van Beek, Roman Vangoitsenhoven, Dilek Yazici, Ramy Younes, Lee M Kaplan

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play